Clinical Trial Update: Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ramelteon for insomnia and mood stability in euthymic bipolar disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ROZEREM (ramelteon)

Snippet

Sponsor: Lehigh Valley Hospital | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2010-07-05